ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/04/20 | 1,419 | 1,431 | 1,401 | 1,408 | -3 | -0.2% | 91,400 |
2016/04/19 | 1,413 | 1,420 | 1,398 | 1,411 | +28 | +2% | 77,300 |
2016/04/18 | 1,381 | 1,397 | 1,381 | 1,383 | -48 | -3.4% | 75,600 |
2016/04/15 | 1,402 | 1,436 | 1,402 | 1,431 | +11 | +0.8% | 72,000 |
2016/04/14 | 1,407 | 1,420 | 1,388 | 1,420 | +38 | +2.7% | 119,400 |
2016/04/13 | 1,383 | 1,394 | 1,369 | 1,382 | +16 | +1.2% | 89,100 |
2016/04/12 | 1,349 | 1,383 | 1,349 | 1,366 | +11 | +0.8% | 67,800 |
2016/04/11 | 1,360 | 1,366 | 1,337 | 1,355 | -16 | -1.2% | 67,800 |
2016/04/08 | 1,319 | 1,386 | 1,315 | 1,371 | +15 | +1.1% | 90,300 |
2016/04/07 | 1,318 | 1,364 | 1,310 | 1,356 | +32 | +2.4% | 73,000 |
2016/04/06 | 1,303 | 1,332 | 1,302 | 1,324 | +5 | +0.4% | 96,700 |
2016/04/05 | 1,355 | 1,372 | 1,315 | 1,319 | -53 | -3.9% | 126,000 |
2016/04/04 | 1,365 | 1,387 | 1,352 | 1,372 | +14 | +1% | 121,700 |
2016/04/01 | 1,431 | 1,434 | 1,352 | 1,358 | -103 | -7% | 200,000 |
2016/03/31 | 1,500 | 1,504 | 1,460 | 1,461 | -30 | -2% | 73,100 |
2016/03/30 | 1,500 | 1,500 | 1,480 | 1,491 | -6 | -0.4% | 49,500 |
2016/03/29 | 1,503 | 1,513 | 1,487 | 1,497 | -31 | -2% | 89,900 |
2016/03/28 | 1,496 | 1,528 | 1,491 | 1,528 | +44 | +3% | 164,300 |
2016/03/25 | 1,499 | 1,499 | 1,465 | 1,484 | -5 | -0.3% | 99,200 |
2016/03/24 | 1,521 | 1,528 | 1,483 | 1,489 | -32 | -2.1% | 111,200 |
2016/03/23 | 1,532 | 1,548 | 1,511 | 1,521 | -4 | -0.3% | 71,600 |
2016/03/22 | 1,492 | 1,525 | 1,487 | 1,525 | +52 | +3.5% | 125,000 |
2016/03/18 | 1,480 | 1,499 | 1,454 | 1,473 | -10 | -0.7% | 134,400 |
2016/03/17 | 1,495 | 1,504 | 1,476 | 1,483 | +4 | +0.3% | 61,700 |
2016/03/16 | 1,494 | 1,502 | 1,477 | 1,479 | -20 | -1.3% | 96,500 |
2016/03/15 | 1,491 | 1,507 | 1,485 | 1,499 | +11 | +0.7% | 77,500 |
2016/03/14 | 1,470 | 1,495 | 1,463 | 1,488 | +34 | +2.3% | 88,300 |
2016/03/11 | 1,434 | 1,455 | 1,424 | 1,454 | +6 | +0.4% | 133,700 |
2016/03/10 | 1,439 | 1,457 | 1,434 | 1,448 | +19 | +1.3% | 59,900 |
2016/03/09 | 1,420 | 1,436 | 1,401 | 1,429 | +3 | +0.2% | 101,600 |
2016/03/08 | 1,460 | 1,461 | 1,417 | 1,426 | -37 | -2.5% | 80,300 |
2016/03/07 | 1,495 | 1,497 | 1,458 | 1,463 | -5 | -0.3% | 64,100 |
2016/03/04 | 1,464 | 1,484 | 1,436 | 1,468 | -2 | -0.1% | 142,100 |
2016/03/03 | 1,465 | 1,475 | 1,457 | 1,470 | ±0 | ±0% | 98,800 |
2016/03/02 | 1,462 | 1,486 | 1,455 | 1,470 | +38 | +2.7% | 78,200 |
2016/03/01 | 1,427 | 1,447 | 1,401 | 1,432 | -3 | -0.2% | 88,200 |
2016/02/29 | 1,450 | 1,480 | 1,435 | 1,435 | +9 | +0.6% | 70,100 |
2016/02/26 | 1,424 | 1,465 | 1,409 | 1,426 | +14 | +1% | 177,100 |
2016/02/25 | 1,367 | 1,417 | 1,367 | 1,412 | +53 | +3.9% | 77,900 |
2016/02/24 | 1,349 | 1,384 | 1,330 | 1,359 | +13 | +1% | 141,800 |
2016/02/23 | 1,398 | 1,398 | 1,342 | 1,346 | -43 | -3.1% | 166,300 |
2016/02/22 | 1,370 | 1,398 | 1,361 | 1,389 | +11 | +0.8% | 73,900 |
2016/02/19 | 1,380 | 1,408 | 1,359 | 1,378 | -25 | -1.8% | 121,000 |
2016/02/18 | 1,396 | 1,428 | 1,382 | 1,403 | +44 | +3.2% | 150,600 |
2016/02/17 | 1,394 | 1,404 | 1,347 | 1,359 | -56 | -4% | 168,600 |
2016/02/16 | 1,410 | 1,451 | 1,401 | 1,415 | -10 | -0.7% | 127,700 |
2016/02/15 | 1,345 | 1,430 | 1,333 | 1,425 | +139 | +10.8% | 166,700 |
2016/02/12 | 1,350 | 1,362 | 1,282 | 1,286 | -116 | -8.3% | 219,900 |
2016/02/10 | 1,464 | 1,476 | 1,391 | 1,402 | -65 | -4.4% | 239,500 |
2016/02/09 | 1,499 | 1,512 | 1,454 | 1,467 | -100 | -6.4% | 143,400 |
2101~
2150
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 226,300円 | +13.6% | +29.2% | 2.03% | 11.74倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 479,000円 | +12.0% | +28.1% | 2.51% | 26.41倍 | 1.12倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 334,000円 | +3.0% | +27.5% | 2.40% | 21.15倍 | 0.92倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 114,400円 | +197.7% | - | 0.00% | 46.75倍 | 1.50倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 150,400円 | +3.2% | +4.5% | 3.46% | 17.28倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム